Article Text

Download PDFPDF
Digitalis: a dangerous drug in atrial fibrillation?
  1. L Testa,
  2. R Bhindi,
  3. A P Banning
  1. Institute of Cardiology, John Radcliffe Hospital, Oxford, UK
  1. Dr L Testa, Institute of Cardiology, John Radcliffe Hospital, Oxford, UK; luctes{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

To the editor: Gjesdal et al1 show the result of an exploratory analysis pooling data from the SPORTIF III and V trials. The authors conclude that digitalis may increase mortality.

We have previously shown that anticoagulation therapy is inversely associated, while digoxin (digitalis) and antiarrhythmic drugs are directly associated, with increased mortality after adjustment for other covariates in patients with atrial fibrillation (AF) treated with a “rate control” compared with patients treated with a “rhythm control” approach.2 …

View Full Text

Linked Articles

  • Featured correspondence
    K Gjesdal J Feyzi S B Olsson